Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Robert M. Dean"'
Autor:
Robert M. Dean, Muhammad Junaid Tariq, Faiz Anwer, Aqsa Ashraf, Malik Qistas Ahmed, Talha Bin Farooq, Arafat Ali Farooqui, Muhammad Salman Faisal, Shaha Nabeel, Abraham S. Kanate, Ahmad Anjum, Saif Ur Rehman, Arshia Akbar
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e414-e426
Chronic lymphocytic leukemia (CLL) typically affects older patients; administration of traditional cytotoxic therapies in old patients has very modest benefit with no survival improvement. With better understanding of CLL biology, trends are shifting
Autor:
Yueh-wei Shen, Allen Xue, Philippe Youkharibache, Mark Roschewski, Norris Lam, Jennifer N. Brudno, John J. Rossi, Lekha Mikkilineni, Brenna Hansen, Nathalie Scholler, Jeremy J. Rose, Robert M. Dean, Ronald E. Gress, Danielle Vanasse, Rashmika Patel, Steven A. Rosenberg, James N. Kochenderfer, Adrian Bot, David F. Stroncek, Raul E. Cachau
Publikováno v:
Nature Medicine. 26:270-280
Anti-CD19 chimeric antigen receptor (CAR)-expressing T cells are an effective treatment for B-cell lymphoma, but often cause neurologic toxicity. We treated 20 patients with B-cell lymphoma on a phase I, first-in-human clinical trial of T cells expre
Autor:
Brian T. Hill, Katherine Tullio, Matt Kalaycio, Navneet S. Majhail, Brad Pohlman, Yazeed Sawalha, Robert M. Dean, Xuefei Jia, Tomas Radivoyevitch, Deepa Jagadeesh
Publikováno v:
Leukemialymphoma. 63(2)
Using the National Cancer Database, we identified 10,290 patients with newly diagnosed mantle cell lymphoma (MCL) treated with chemotherapy with or without upfront autologous stem cell transplantation (ASCT). Only 17% of patients underwent ASCT. Pati
Autor:
Tamila L. Kindwall-Keller, Uday R. Popat, Jaroslaw P. Maciejewski, Bronwen E. Shaw, Robert J. Hayashi, Remco J. Molenaar, Navneet S. Majhail, David I. Marks, Robert F. Cornell, Adriana K. Malone, Richard F. Olsson, Ruta Brazauskas, Jean-Yves Cahn, Basem M. William, Nandita Khera, Joseph W. Fay, Amer Beitinjaneh, Ibrahim Ahmed, Amir Steinberg, Heather Landau, Yoshihiro Inamoto, Peiman Hematti, Heather B. Allewelt, Anne B. Warwick, Kimberly A. Kasow, Mary E.D. Flowers, Harry C. Schouten, Anita D'Souza, Jennifer Holter Chakrabarty, Minoo Battiwalla, Tomas Radivoyevitch, Robert M. Dean, Baldeep Wirk, Gorgun Akpek, Siddhartha Ganguly, Shahrukh K. Hashmi, Sonata Jodele, J. Douglas Rizzo, Matt Kalaycio, Zachariah DeFilipp, Robert Peter Gale, William A. Wood, Hillard M. Lazarus, Andrew Daly, Kenneth R. Cooke, Anuj Mahindra, Muneer H. Abidi, Heather R. Tecca, Sachiko Seo, Ashish Bajel, Betty K. Hamilton, Mahmoud Aljurf, David Buchbinder, Rachel J. Cook, Mark R. Litzow, Jean A. Yared, Gregory A. Hale, Bipin N. Savani, Mikkael A. Sekeres, Mehdi Hamadani
Publikováno v:
Leukemia research, 74, 130-136. Elsevier Limited
Background Exposures to DNA-damaging drugs and ionizing radiations increase risks of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Methods 9028 recipients of hematopoietic cell autotransplants (1995–2010) for Hodgkin lymphoma (HL
Autor:
Betty K. Hamilton, Matt Kalaycio, Navneet S. Majhail, Steven Andresen, Yazeed Sawalha, Danyu Sun, Mitchell R. Smith, Deepa Jagadeesh, Lisa Rybicki, Hien Liu, Brian J. Bolwell, Brad Pohlman, Aaron T. Gerds, Brian T. Hill, Robert M. Dean, Ronald Sobecks
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 18:e95-e102
Background Young fit patients with mantle cell lymphoma (MCL) are commonly treated with induction chemotherapy followed by high-dose chemotherapy and autologous hematopoietic cell transplantation (AHCT). Induction regimens with modifications of R-CHO
Autor:
Matt Kalaycio, Jack Khouri, Robert M. Dean, Donna Corrigan, Brad Pohlman, Aaron T. Gerds, Brian T. Hill, Betty K. Hamilton, Deepa Jagadeesh, Navneet S. Majhail, Brian J. Bolwell, Hien D. Liu, Ronald Sobecks, Frederic J. Reu
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e374-e376
Autor:
Yazan F. Madanat, Brian T. Hill, Lisa Rybicki, Tomas Radivoyevitch, Mitchell R. Smith, Brad Pohlman, Robert M. Dean, Mikkael A. Sekeres, Deepa Jagadeesh, Matt Kalaycio
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:857-862
Hairy cell leukemia (HCL) is a rare hematologic malignancy with high response rates and long progression-free survival (PFS) after treatment with purine nucleoside analogs (PNAs; Pentostatin/Cladribine). However, treatment is not curative, and subseq
Autor:
John W. Sweetenham, Deepa Jagadeesh, Meredeth Shelley, Brian J. Bolwell, Brian T. Hill, Mitchell R. Smith, Brad Pohlman, Robert M. Dean, Stephen D. Smith
Publikováno v:
Leukemia & Lymphoma. 59:690-694
B-cell non-Hodgkin lymphomas (NHL) display dysregulation of pathways controlling cell proliferation and apoptosis. Combined proteasome and mTOR inhibition, demonstrated with bortezomib and everolimus in a preclinical model, thus warrants evaluation i
Autor:
Robert M. Dean, Hillard M. Lazarus, Christy J. Samaras, Frederic J. Reu, Hien Liu, Janice Reed, Nathaniel Rosko, Eshan Malek, Dale Grabowski, Kimberly Hamilton, Jason Valent, Yogen Saunthararajah, Sherry Fada, Reda Z. Mahfouz, Wei Wei, Jack Khouri, Mary Ann Karam, Beth Faiman, Matt Kalaycio, Yap Chew
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e262-e263
Autor:
Danielle Vanasse, Steven A. Rosenberg, Philippe Youkharibache, Jennifer N. Brudno, Robert M. Dean, Jeremy J. Rose, Mark Roschewski, Nathalie Scholler, Ronald E. Gress, Brenna Hansen, Lekha Mikkilineni, Rashmika Patel, Raul E. Cachau, John J. Rossi, Norris Lam, David F. Stroncek, James N. Kochenderfer, Adrian Bot, Yueh-wei Shen, Allen Xue
Publikováno v:
Nature Medicine. 26:803-803